US6262047B1
(en)
|
1996-10-11 |
2001-07-17 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6369080B2
(en)
|
1996-10-11 |
2002-04-09 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6194435B1
(en)
|
1996-10-11 |
2001-02-27 |
Cor Therapeutics, Inc. |
Lactams as selective factor Xa inhibitors
|
US6063794A
(en)
|
1996-10-11 |
2000-05-16 |
Cor Therapeutics Inc. |
Selective factor Xa inhibitors
|
EP0977773A1
(en)
|
1997-04-14 |
2000-02-09 |
Cor Therapeutics, Inc. |
SELECTIVE FACTOR Xa INHIBITORS
|
US6204268B1
(en)
|
1997-04-14 |
2001-03-20 |
Cor Therapeutics, Inc |
Selective factor Xa inhibitors
|
CA2285705A1
(en)
*
|
1997-04-14 |
1998-10-22 |
Cor Therapeutics, Inc. |
Selective factor xa inhibitors
|
CA2287569A1
(en)
*
|
1997-05-02 |
1998-11-12 |
Akzo Nobel Nv |
Serine protease inhibitors
|
US6218382B1
(en)
|
1997-08-11 |
2001-04-17 |
Cor Therapeutics, Inc |
Selective factor Xa inhibitors
|
US6228854B1
(en)
|
1997-08-11 |
2001-05-08 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
US6333321B1
(en)
|
1997-08-11 |
2001-12-25 |
Cor Therapeutics, Inc. |
Selective factor Xa inhibitors
|
CN1291892A
(en)
*
|
1998-01-27 |
2001-04-18 |
阿温蒂斯药物制品公司 |
Substituted oxoazaheterocyclyl factor Xa inhibitors
|
US6323219B1
(en)
|
1998-04-02 |
2001-11-27 |
Ortho-Mcneil Pharmaceutical, Inc. |
Methods for treating immunomediated inflammatory disorders
|
CN1769274A
(en)
|
1998-06-11 |
2006-05-10 |
奥瑟-麦内尔制药公司 |
pyrazinone protease inhibitor
|
US8093293B2
(en)
|
1998-07-06 |
2012-01-10 |
Johnson & Johnson Consumer Companies, Inc. |
Methods for treating skin conditions
|
US8106094B2
(en)
|
1998-07-06 |
2012-01-31 |
Johnson & Johnson Consumer Companies, Inc. |
Compositions and methods for treating skin conditions
|
DE19835950A1
(en)
*
|
1998-08-08 |
2000-02-10 |
Merck Patent Gmbh |
Piperazinone derivatives
|
DK0997474T3
(en)
|
1998-08-14 |
2004-02-09 |
Pfizer |
Antithrombotic agents
|
CA2320730A1
(en)
*
|
1998-12-23 |
2000-07-06 |
Renhua Li |
Thrombin or factor xa inhibitors
|
WO2000044733A1
(en)
|
1999-01-27 |
2000-08-03 |
Ortho-Mcneil Pharmaceutical, Inc. |
Peptidyl heterocyclic ketones useful as tryptase inhibitors
|
US6906068B1
(en)
|
1999-05-19 |
2005-06-14 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants
|
US6867217B1
(en)
|
1999-05-19 |
2005-03-15 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade
|
US7015230B1
(en)
|
1999-05-19 |
2006-03-21 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl uracils useful for selective inhibition of the coagulation cascade
|
US6750342B1
(en)
|
1999-05-19 |
2004-06-15 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
US6908919B2
(en)
*
|
1999-05-19 |
2005-06-21 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
|
US6664255B1
(en)
|
1999-05-19 |
2003-12-16 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
|
US6653316B1
(en)
|
1999-05-19 |
2003-11-25 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade
|
US6716838B1
(en)
|
1999-05-19 |
2004-04-06 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents
|
FR2795072B1
(en)
*
|
1999-06-15 |
2001-07-27 |
Adir |
NOVEL BICYCLIC DERIVATIVES OF AMINO-PYRAZINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
|
US7309688B2
(en)
|
2000-10-27 |
2007-12-18 |
Johnson & Johnson Consumer Companies |
Topical anti-cancer compositions and methods of use thereof
|
WO2001068605A1
(en)
|
2000-03-13 |
2001-09-20 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted benzenes useful for selective inhibition of the coagulation cascade
|
CA2405561A1
(en)
|
2000-04-05 |
2001-10-18 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted 4-pyrones useful for selective inhibition of the coagulation cascade
|
CA2405306A1
(en)
|
2000-04-05 |
2001-10-18 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade
|
WO2001079155A2
(en)
|
2000-04-17 |
2001-10-25 |
Pharmacia Corporation |
Polycyclic aryl and heteroaryl substituted 1,4-quinones useful for selective inhibition of the coagulation cascade
|
MXPA03000512A
(en)
|
2000-07-17 |
2003-10-06 |
Dimensional Pharm Inc |
Cyclic oxyguanidine pyrazinones as protease inhibitors.
|
PE20020420A1
(en)
|
2000-10-02 |
2002-06-27 |
Novartis Ag |
DERIVATIVES OF DIAZACICLOALKANODIONA AS ANTAGONISTS OF ANTIGEN ASSOCIATED WITH LYMPHOCYTE-1 FUNCTION (LFA-1)
|
US8431550B2
(en)
|
2000-10-27 |
2013-04-30 |
Johnson & Johnson Consumer Companies, Inc. |
Topical anti-cancer compositions and methods of use thereof
|
US6710058B2
(en)
|
2000-11-06 |
2004-03-23 |
Bristol-Myers Squibb Pharma Company |
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
|
JP2004517074A
(en)
|
2000-11-20 |
2004-06-10 |
ファルマシア・コーポレーション |
Substituted polycyclic aryl and heteroaryl pyridines useful for selectively inhibiting the coagulation cascade
|
US7015223B1
(en)
|
2000-11-20 |
2006-03-21 |
Pharmacia Corporation |
Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade
|
US7119094B1
(en)
|
2000-11-20 |
2006-10-10 |
Warner-Lambert Company |
Substituted polycyclic aryl and heteroarpyl pyrazinones useful for selective inhibition of the coagulation cascade
|
US7192615B2
(en)
|
2001-02-28 |
2007-03-20 |
J&J Consumer Companies, Inc. |
Compositions containing legume products
|
US6969715B2
(en)
|
2001-10-03 |
2005-11-29 |
Pharmacia Corporation |
6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
|
CA2462645A1
(en)
|
2001-10-03 |
2003-11-13 |
Pharmacia Corporation |
Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
|
RU2334760C2
(en)
|
2002-03-22 |
2008-09-27 |
Гпц Биотек Аг |
Immunosuppressive agents
|
CA2507707C
(en)
|
2002-12-03 |
2011-06-21 |
Axys Pharmaceuticals, Inc. |
2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
|
DK3204352T3
(en)
|
2014-10-06 |
2020-09-28 |
Cortexyme Inc |
Inhibitors of lysine-gingipain
|
JP6877424B2
(en)
|
2015-11-09 |
2021-05-26 |
コーテクシーミー, インコーポレイテッド |
Inhibitor of arginine gingipain
|
DK3512846T3
(en)
|
2016-09-16 |
2024-11-11 |
Lighthouse Pharmaceuticals Inc |
Ketone inhibitors of lysine-gingipain
|
JOP20190245A1
(en)
|
2017-04-20 |
2019-10-15 |
Novartis Ag |
Sustained release delivery systems comprising traceless linkers
|
AR116566A1
(en)
|
2018-10-03 |
2021-05-19 |
Novartis Ag |
SUSTAINED ADMINISTRATION OF ANGIOPOYETIN-SIMILAR POLIPEPTIDES 3
|